ConductScience.org, home

Paper198084

Immunotherapy with autologous white cell infusions ("lymphocytes") in the treatment of recurrrent glioblastoma multiforme: a preliminary report.

Young H and 2 others. Cancer, 1977. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Immunotherapy with autologous white cell infusions ("lymphocytes") in the treatment of recurrrent glioblastoma multiforme: a preliminary report. Papers, record 198084. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/198084

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy with autologous white cell infusions ("lymphocytes") in the treatment of recurrrent glioblastoma multiforme: a preliminary report.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Young HH
2Kaplan AA
3Regelson WW

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
GlioblastomaMajor topic
Lymphocyte TransfusionMajor topic
Adult
Aged
Cytotoxicity, Immunologic
Female
Humans
Immunotherapy
Lymphocytes
Male
Middle Aged
Remission, Spontaneous
Time Factors
Transplantation, Autologous

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
41707655Cell therapy for brain tumors: The first 60 years.Cell Rep Med2026https://conductscience.org/library/papers/41707655PubMed
35203636Immunotherapeutic Approaches for Glioblastoma Treatment.Biomedicines2022https://conductscience.org/library/papers/35203636PubMed
33176788Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.J Transl Med2020https://conductscience.org/library/papers/33176788PubMed
31747788Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.CNS Oncol2019https://conductscience.org/library/papers/31747788PubMed
21395383Cellular immunotherapy for high-grade glioma.Immunotherapy2011https://conductscience.org/library/papers/21395383PubMed
19560742Toward effective immunotherapy for the treatment of malignant brain tumors.Neurotherapeutics2009https://conductscience.org/library/papers/19560742PubMed
18363995Immunotherapy of malignant brain tumors.Immunol Rev2008https://conductscience.org/library/papers/18363995PubMed
16410822Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.Cancer Gene Ther2006https://conductscience.org/library/papers/16410822PubMed
8699235Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors.J Neurooncol1996https://conductscience.org/library/papers/8699235PubMed
7015801The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.Acta Neurochir (Wien)1981https://conductscience.org/library/papers/7015801PubMed
6611523Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.Neurosurg Rev1984https://conductscience.org/library/papers/6611523PubMed
6090602Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.J Neurooncol1984https://conductscience.org/library/papers/6090602PubMed
3966985A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.Br J Cancer1985https://conductscience.org/library/papers/3966985PubMed
3494820Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor.J Neurooncol1987https://conductscience.org/library/papers/3494820PubMed
3434340Intrathecal injection of autologous leucocytes in glioblastoma: circulatory dynamics within the subarachnoid space and clinical results.Acta Neurochir (Wien)1987https://conductscience.org/library/papers/3434340PubMed
2702675Treatment of glioma with intratumoral instillation of autologous lymphocytes.Childs Nerv Syst1989https://conductscience.org/library/papers/2702675PubMed
2472737Intratumoural injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma.Acta Neurochir (Wien)1989https://conductscience.org/library/papers/2472737PubMed
2068965Immunotherapy of glioblastoma with intratumoural administration of autologous lymphocytes and human lymphoblastoid interferon. A further clinical study.Acta Neurochir (Wien)1991https://conductscience.org/library/papers/2068965PubMed
1744686Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.J Neurooncol1991https://conductscience.org/library/papers/1744686PubMed
1716671Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.J Neurooncol1991https://conductscience.org/library/papers/1716671PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/198084

GET https://conductscience.org/api/papers/v1/198084/authors